Ann Neuer

How asking better questions and leveraging site databases can expand access to more patients.

Hybrid studies, patient-centric tools, and collaborations create big changes for clinical trials and stakeholders during COVID-19.

Clinical trial stakeholders weigh in on the major shifts unfolding in the era of COVID-19, as efforts move away from the traditional site-based model.